openPR Logo
Press release

Clinical Trial Management System (CTMS) Market : Trends estimates high demand by 2025

07-17-2017 04:08 PM CET | Health & Medicine

Press release from: TMR Research

Clinical Trial Management System (CTMS) Market : Trends

Global Clinical Trial Management System (CTMS) Market: Overview

A clinical trial management system (CTMS) is a software system that is used to maintain and manage trials in clinical research activities. The system manages planning and executing and reporting functions, along with contact information of participant. In addition, it is useful in tracking deadlines and milestones of trials. CTMSs are used primarily used in pharmaceutical and biotech organizations, medical devices industry, and clinical research companies.

Global Clinical Trial Management System (CTMS) Market: Key Trends

The increasing research and development activities in the field of life science and clinical research is the foremost factor driving the demand for CTMS. The growing investments from public and private sectors and the introduction of conducive government policies are paving way for increased number of clinical trials, which turn is providing a fillip to the market. However, the dearth of skilled professionals is hampering the growth of the market. Moreover, the high deployment cost of these systems along with budgetary constraints of small and medium-sized organizations is keeping the market from realizing its utmost potential.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=1403

Global Clinical Trial Management System (CTMS) Market: Market Potential

The global CTMS market is set to witness a transformation as end users shift their focus from loosely integrated back-office data capture and aggregation technologies to cloud-based tools and development platforms that enable real-time solutions. For instance, in June 2016, Pfizer invested in the Oracle Siebel Clinical Trial Management and Monitoring Cloud Service and the Oracle Health Sciences InForm Cloud Service. The services would help the company in managing and monitoring more than 300 clinical trials per year and providing best-in-class solutions.

Developing products that can better adapt and scale to suit the requirements of end users will be another prominent trend among vendors in the market in the foreseeable future. To put this perspective, in February 2017, OmniComm Systems announced its plans to come under one roof with Bio-Optronics to integrate their proprietary products, namely Clinical Conductor®, a CTMS from Bio-Optronics, and TrialMaster® EDC – an electronic data capture (EDC) system from OmniComm. The development of this product is under the agreement with a major institution seeking to develop treatments for cancer and other chronic diseases.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=1403

Global Clinical Trial Management System (CTMS) Market: Geographical Segmentation

The key segments analyzed in the report on the basis of geography are Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America will be a major revenue contributor during the review period. The growth of the region can be attributed to the presence of advanced IT infrastructure. The U.S. will account for a substantial share in the regional market, owing to favorable government initiatives.

Asia Pacific is expected to progress at a tremendous CAGR during the same period. The rising efforts by governments towards improving the healthcare infrastructure and increasing research and development activities in the field of medicines coupled with the growing trend of outsourcing of clinical trials are escalating the growth of the region. The expanding base of patient population and rapid digitization are also promoting the adoption of CTMS in APAC. Countries such as China and India will be sights of high growth in the region.

Europe will also reflect significant growth in the forthcoming years. The increasing emphasis on the development of novel drugs for the treatment of chronic disease coupled with the growing investments by governments is stimulating the demand for CTMS in the region. The growth of Latin America is largely supplemented by the rising adoption of biomedical devices and advancements in clinical trials.

Read Comprehensive Overview of Report@ www.tmrresearch.com/clinical-trial-management-system-market

Global Clinical Trial Management System (CTMS) Market: Competitive Landscape

The global CTMS market features high competition among key players on the basis of performance, product, and technology. Several players are focusing towards vertical integration to enhance their service efficiency and delivery. Some of the prominent companies operating in the market are MedNet Solutions, Oracle Corporation, Bio-Optronics, BioClinica, Parexel International Corporation, and Medidata solutions.

About TMR Research :

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Management System (CTMS) Market : Trends estimates high demand by 2025 here

News-ID: 627579 • Views: 193

More Releases from TMR Research

Sucralose Market is Booming Worldwide | Evolva Holding, JK Sucralose, Galam Ltd.
Global Sucralose Market: Overview Increased disposable income among expanding base of urban population is stroking the food and beverage industry, but at the same time, obesity, diabetes, and heart diseases are becoming more ubiquitous than ever before. In these times, the demand for artificial sweeteners that can adequately match the taste buds of consumers with minimal quantity is being extended by the food manufacturers. Consequently, the demand for sucralose is on
Cataract Market By Major Players, Development, Opportunities, Market Driving For …
Global Cataract Market: Overview A cataract is an ocular disease in which the lens of an individual’s eye degrades progressively and turns opaque, resulting in blurred vision. If ignored, the condition can lead to vision loss. Cataracts progress slowly with age and people commonly do not realize that they are suffering from cataract as it grows very slowly and may not impede the vision immediately. Order Brochure for more Detailed Information
Fungal Infections Market (2017-2025) thriving worldwide by - Samyang Corporation …
Global Fungal Infections Market: Overview Fungi, which includes yeasts, molds, and mildews are some of the common parasites that infect different parts of the human body. Lungs, genitals, skin, digestive tract, liver, and other tissues are commonly affected by fungal infections. There are some rare types of fungal infections such as fungal keratitis, mucormycosis, and hisptoplasmosis for which treatment is not available. This has led many fungal infections market players
Diffuse Large B-Cell Lymphoma Market Sales Volume, Status, Growth, Opportunities …
Diffuse Large B-Cell Lymphoma Market: Overview With a noticeable rise in the prevalence of diffuse large B-cell lymphoma (DLBCL), the market for DLBCL market is witnessing strong growth across the world. Analysts expect the trend to remain so over the next few years, owing to the increasing number of elderly people, the most prone to DLBCL segment of the overall population. Diffuse large B-cell lymphoma (DLBCL) is the most common

All 5 Releases


More Releases for CTMS

Clinical Trial Management System (CTMS) Market - Revolutionary Scope 2025 | MedN …
Clinical Trial Management System (CTMS) Market : Snapshot The global clinical trial management system market is mainly driven by the heightened occurrences of chronic diseases among people. The rise in the outsourcing of clinical trials is another reason, why this market is expected to flourish in the coming years. Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1403 Moreover, favorable government initiatives are also anticipated to aid the growth of the global clinical trial
Clinical Trial Management System (CTMS) Market Demand Prophesy 2025- MedNet Solu …
Clinical Trial Management System (CTMS) Market : Snapshot The global clinical trial management system market is mainly driven by the heightened occurrences of chronic diseases among people. The rise in the outsourcing of clinical trials is another reason, why this market is expected to flourish in the coming years. Moreover, favorable government initiatives are also anticipated to aid the growth of the global clinical trial management system market. In addition to
Clinical Trial Management System (CTMS) Market commanding maximum share 2025
Clinical Trial Management System (CTMS) Market : Snapshot The global clinical trial management system market is mainly driven by the heightened occurrences of chronic diseases among people. The rise in the outsourcing of clinical trials is another reason, why this market is expected to flourish in the coming years. Moreover, favorable government initiatives are also anticipated to aid the growth of the global clinical trial management system market. In addition to
Clinical Trial Management System (CTMS) Market Prophesy In 2025
Clinical Trial Management System (CTMS) Market : Snapshot The global clinical trial management system market is mainly driven by the heightened occurrences of chronic diseases among people. The rise in the outsourcing of clinical trials is another reason, why this market is expected to flourish in the coming years. Moreover, favorable government initiatives are also anticipated to aid the growth of the global clinical trial management system market. In addition to
Clinical Trial Management System (CTMS) Market Foreseeable Future by 2025
Clinical Trial Management System (CTMS) Market : Snapshot The global clinical trial management system market is mainly driven by the heightened occurrences of chronic diseases among people. The rise in the outsourcing of clinical trials is another reason, why this market is expected to flourish in the coming years. Moreover, favorable government initiatives are also anticipated to aid the growth of the global clinical trial management system market. In addition to
Bio-Optronics Announces Advanced Business Intelligence Reporting for CTMS
February 9, 2017 – ROCHESTER, NY – Bio-Optronics, the makers of the market-leading Clinical Conductor clinical trial management system (CTMS) announces the release of an advanced business intelligence (BI) reporting module designed to provide health systems, CROs and other research organizations real-time access to analytics that drive decisions and business growth. The BI reporting tool, available as a module in Clinical Conductor CTMS, allows users to quickly create recurring and ad-hoc